Details for 2016804177

Up to date per 03.04.2026

Actions

Title / Product Name

CERDULATINIB ZUR BEHANDLUNG VON B-ZELL-MALIGNOMEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016804177

EP Publication Number

3302485

E-Number

1586361

Language

PCT Number

US16034861

Publication Date

11.04.2018 A

12.07.2023 B1

Registration Date

12.07.2023

AT Publication Date

15.08.2023

Application Date

27.05.2016

Registration Number

Priorities

29.05.2015

201562168530 P

04.12.2015

201562263582 P

IPC

A61K 31/506 20060101AFI20190124BHEP

Maximum Duration of Protection

27.05.2036

Owner

Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US

Representative

No representatives present

Inventor

PANDEY, Anjalic/o Portola Pharmaceuticals, Inc. 270 E. Grand Avenue South San Francisco, California 94080US

COFFEY, Gregoryc/o Portola Pharmaceuticals, Inc. 270 E. Grand Avenue South San Francisco, California 94080US

LEEDS, Janetc/o Portola Pharmaceuticals, Inc. 270 E. Grand Avenue South San Francisco, California 94080US